Obesity
Key Points
Key Points
- The Task Force agrees with the opinion of prominent medical societies that current scientific evidence supports the view that obesity is a disease.
- Weight loss produces many benefits including risk factor improvement, prevention of disease, and improvements in feeling and function. Greater weight loss produces greater benefits, but modest (5%–10%) weight loss, such as that produced by lifestyle modifications and medications, has been shown to produce significant improvements in many conditions.
- Medications used for the management of conditions other than obesity can contribute to or exacerbate weight gain in susceptible individuals. Many of these conditions are also associated with obesity.
- Health care providers can help patients prevent or attenuate weight gain by appropriately prescribing medications that would promote weight loss or minimize weight gain when treating these conditions.
- Health care providers can help selected patients successfully lose weight and maintain lost weight by appropriately prescribing weight loss medications or in some cases surgical intervention as an adjunct to lifestyle change.
Diagnosis
...agnosis
...uses of ObesityHaving trouble viewing ta...
...ble 2. Comorbid Conditions in Obesity and Ev...
Treatment
...atment
...ine Society (ES) recommends that diet, exercise,...
...to promote long-term weight maintenance,...
...patients with uncontrolled HTN or histor...
...essment of efficacy and safety at leas...
...tient’s response to a weight loss medica...
...edication for chronic obesity management i...
...patients with T2DM who are overweight or obe...
...h CVD who seek pharmacological treatmen...
...That Cause Weight Gain and Some Alternatives...
...ommends weight-losing and weight-neut...
...obese patients with T2DM requiring ins...
...s ACE inhibitors, angiotensin receptor blockers...
...n antidepressant therapy is indicated, E...
...ecommends using weight-neutral antipsychotic alter...
...recommends considering weight gain p...
...with a BMI >27 kg/m2 with comorbidi...
...ests monitoring the weight and waist ci...
...sts the use of NSAIDs and disease-modifyi...
...use of antihistamines with less central nervous s...
...ff-Label Use of Drugs Approved for Other Indicati...
...nst the off-label use of medications approv...
...gs Associated with Weight Gain and Sug...
...dvantages and Disadvantages Associat...
...cotherapy for Obesity in the United StatesHaving t...